Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease

Benoît Melchior(Samumed (United States)), Yusuf Yazıcı(Samumed (United States))

Aging Cell

July 3, 2019

10.1111/acel.13000

Cited by 64

Related Papers

No related papers found

Powered by citation graph analysis